GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Methylphenidate Hydrochloride Prolonged-Release Tablets IP 10mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Methylphenidate Hydrochloride Prolonged-Release Tablets IP 10mg
Each film-coated prolonged-release tablet contains:
Methylphenidate Hydrochloride IP…………. 10mg
Excipients…………………………………………….……. q. s
Color: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

Methylphenidate is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE X PRESCRIPTION DRUG-WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.

STORAGE & DOSAGE:

STORAGE: Store in a dry place, protected from light & moisture.
DOSAGE: As directed by the Psychiatrists.

Methylphenidate Hydrochloride Prolonged-Release Tablets IP 10mg Technical Specification:

Product Name: Methylphenidate Hydrochloride Prolonged-Release Tablets IP
Brand Name: Generic
Strength: (10mg)
Dosage Form: Tablets (film coated- PR)
Route of Administration: Via Oral Route
Packing: 10s, 30s, 100s, 500s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Central Nervous System Stimulants.
Indication: Methylphenidate is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
Storage: Store in a dry place, protected from light & moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Methylphenidate Hydrochloride Prolonged-Release Tablets IP 10mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Methylphenidate Hydrochloride Prolonged-Release Tablets IP 10mg
Each film-coated prolonged-release tablet contains:

Methylphenidate Hydrochloride IP…………… 10mg
Excipients……………………………………………. q. s
Color: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

Methylphenidate is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH

SCHEDULE X PRESCRIPTION DRUG-WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.

STORAGE & DOSAGE:

STORAGE: Store in a dry place, protected from light & moisture.

DOSAGE: As directed by the Psychiatrists.